申请人:Hashimoto Masaya
公开号:US20070015792A1
公开(公告)日:2007-01-18
The invention provides the compounds represented by the formula (I)
in which, R stands for a dihydroxy-substituted C
1
-C
6
alkyl group, and Cy stands for an optionally substituted C
6
-C
10
bi- or tri-cyclic aliphatic carbocyclic group. These compounds act as nociceptin receptor antagonist, and are useful, for example, as relievers against tolerance to narcotic analgesic, dependence on narcotic analgesic or addiction; analgesic enhancers; antiobestic or appetite suppressors; treating or prophylactic agents for cognitive impairment and dementia/amnesia; agents for treating developmental cognitive abnormality; remedy for schizophrenia; agents for treating neurodegenerative diseases; anti-depressant or treating agents for affective disorder; treating or prophylactic agents for diabetes insipidus; treating or prophylactic agents for polyuria; and remedy for hypotension and the like.
该发明提供了由式(I)表示的化合物,其中R代表二羟基取代的C1-C6烷基基团,Cy代表一个可选择取代的C6-C10双环或三环脂肪环碳环基团。这些化合物作为痛觉受体拮抗剂,例如,可用作缓解对麻醉镇痛药的耐受性、对麻醉镇痛药的依赖或成瘾的药物;镇痛增强剂;抗肥胖或食欲抑制剂;治疗或预防认知障碍和失忆症/健忘症的药物;治疗发育性认知异常的药物;治疗精神分裂症的药物;治疗神经退行性疾病的药物;抗抑郁或治疗情感障碍的药物;治疗或预防尿崩症的药物;治疗或预防多尿症的药物;以及治疗低血压等的药物。